
Metformin Extended-Release (Er/Xr) Tablets
Form: Extended-Release (ER/XR) Tablets
Strength: 500 mg, 750 mg, 1000 mg
Reference Brands: Glucophage XR®, Fortamet®, Glumetza®
Category: Diabetes
Metformin Extended-Release (ER/XR) tablets are approved in both the USA and EU for the treatment of type 2 diabetes mellitus. In the USA, they are regulated under the FDA’s NDA and ANDA pathways, with several generic approvals available. Common brands include Glucophage XR and Fortamet. In the EU, Metformin ER is authorized via national procedures and is included in multiple Member States' formularies. ER formulations improve gastrointestinal tolerability and enhance patient adherence by allowing once-daily dosing. Pharmatradz.com supports global buyers in sourcing Metformin ER tablets from GMP-certified manufacturers compliant with FDA and EMA quality standards.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Premixed Insulins (70/30, 50/50) Injectable
Strength: U-100
Form: Vials, pens
Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)
View DetailsInsulin Lispro (Humalog) Injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)
View DetailsInsulin Aspart (Novolog) Injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Novolog, Fiasp(US &EU)
View DetailsInsulin Glargine (Lantus) Injectable
Strength: U-100, U-300
Form: Vials/pens
Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)
View Details